Bank of America
SLXP

Bank of America’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bank of America’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-28,500
Closed -$4.92M – 7685
2015
Q1 		$4.92M Sell
28,500
-700
-2% -$103K ﹤0.01% 2503
2014
Q4 		$3.36M Buy
29,200
+11,100
+61% +$1.34M ﹤0.01% 2900
2014
Q3 		$2.83M Sell
18,100
-21,400
-54% -$3.1M ﹤0.01% 3072
2014
Q2 		$4.87M Buy
39,500
+10,300
+35% +$1.14M ﹤0.01% 2587
2014
Q1 		$3.02M Sell
29,200
-3,900
-12% -$399K ﹤0.01% 2839
2013
Q4 		$2.98M Buy
33,100
+16,100
+95% +$1.28M ﹤0.01% 2940
2013
Q3 		$1.14M Hold
17,000
– – ﹤0.01% 3823
2013
Q2 		$1.13M Buy
+17,000
New +$972K ﹤0.01% 3893

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Bank of America's SLXP Position: Q2 2015 in Review

Bank of America sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 358,907 shares — an estimated $62M sold.

Bank of America first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $199M in Q2 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Bank of America reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Bank of America sold 358,907 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $62M.
  • Bank of America first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Bank of America's SALIX PHARMACEUTICALS LTD DEL position peaked at $199M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Bank of America's 13F filing for Q2 2015, filed 14 Aug 2015.